{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:27:29Z","timestamp":1787048849775,"version":"build-2736575974"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"German Federal Ministry for Education and Research under the acronym \u201cImmuTherM\u201d","award":["031L0156"],"award-info":[{"award-number":["031L0156"]}]},{"DOI":"10.13039\/100021828","name":"German Academic Exchange Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastatic disease is the prime cause of death from many malignancies. Due to the multiple different lesions and the increased aggressiveness of the cancer cells, metastatic disease is often difficult to treat. Here, the introduction of immune checkpoint blockers (ICBs) has greatly helped to improve patients\u2019 prognosis by harnessing antitumor immunity, particularly anticancer T cells in multiple human cancers. Despite the success of ICBs in, for example, metastatic melanoma 2 major challenges remain in the field: therapy-limiting toxicities induced by systemic ICB administration and lack of a life-prolonging response in a substantial number of patients. Therefore, highly potent local immunotherapeutic approaches might offer a solution and enhance treatment of metastatic disease. Here, we describe antibody-functionalized paramagnetic microbeads as a means to fill this void. These microbeads are readily engulfed by the vast majority of human cancer cell line cells studied inducing direct cytotoxicity (first hit). Focusing on malignant melanoma, we further observed that loading the microbeads with a conventional anti-CD28 monoclonal antibody (bead-bound conventional anti-CD28 monoclonal antibody, BBC-28) not only efficiently induced proliferation and cytokine release by human T cells expressing CD28, but also enhanced killing of melanoma cells by melanoma-reactive T cells (second hit). Thus, we provide proof-of-concept data that BBC-28, after local application into, for example, skin metastases, may also induce a combination of direct toxicity and enhanced anticancer immunity, leading to efficient treatment of metastatic disease.<\/jats:p>","DOI":"10.1093\/jimmun\/vkag191","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:35:59Z","timestamp":1787045759000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy of malignant melanoma using T cell\u2013activating microbeads"],"prefix":"10.1093","volume":"215","author":[{"given":"Nada T","family":"Hassan","sequence":"first","affiliation":[{"name":"Institute for Virology and Immunobiology, University of W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"L\u00f6ffler","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunobiology, University of W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Sachs dos Santos","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunobiology, University of W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wohlfarth","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliane","family":"Wu\u00dfmann","sequence":"additional","affiliation":[{"name":"Fraunhofer Translational Center Regenerative Therapies (TLC-RT) , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Schellhammer","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Animal Science, University of Z\u00fcrich , Schlieren,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"vom Berg","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Animal Science, University of Z\u00fcrich , Schlieren,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Groeber-Becker","sequence":"additional","affiliation":[{"name":"Fraunhofer Translational Center Regenerative Therapies (TLC-RT) , W\u00fcrzburg,","place":["Germany"]},{"name":"Department of Ophthalmology, University Clinic D\u00fcsseldorf , D\u00fcsseldorf,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerkau","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunobiology, University of W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-4103","authenticated-orcid":false,"given":"Bastian","family":"Schilling","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital, Goethe University Frankfurt , Frankfurt,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Beyersdorf","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunobiology, University of W\u00fcrzburg , W\u00fcrzburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026081805465352900_vkag191-B1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026081805465352900_vkag191-B2","doi-asserted-by":"crossref","first-page":"573141","DOI":"10.3389\/fonc.2020.573141","article-title":"Significance of tumor mutation burden in immune infiltration and prognosis in Cutaneous Melanoma","volume":"10","author":"Kang","year":"2020","journal-title":"Front Oncol"},{"key":"2026081805465352900_vkag191-B3","volume-title":"Cutaneous melanoma: etiology and therapy","author":"Matthews","year":"2017"},{"key":"2026081805465352900_vkag191-B4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40257-020-00509-z","article-title":"Long-term outcomes in BRAF-mutated melanoma treated with combined targeted therapy or immune checkpoint blockade: are we approaching a true cure?","volume":"21","author":"Schummer","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"2026081805465352900_vkag191-B5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.csbj.2019.03.006","article-title":"Application of PD-1 blockade in Cancer immunotherapy","volume":"17","author":"Wu","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"2026081805465352900_vkag191-B6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2026081805465352900_vkag191-B7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PPO.0000000000000303","article-title":"Mechanisms of resistance to PD-1 and PD-L1 blockade","volume":"24","author":"Nowicki","year":"2018","journal-title":"Cancer J"},{"key":"2026081805465352900_vkag191-B8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"2026081805465352900_vkag191-B9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/emp2.12209","article-title":"Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department","volume":"1","author":"Yeung","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2026081805465352900_vkag191-B10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"2026081805465352900_vkag191-B11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"key":"2026081805465352900_vkag191-B12","doi-asserted-by":"crossref","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026081805465352900_vkag191-B14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3389\/fimmu.2018.01060","article-title":"CD28 Costimulation of T helper 1 cells enhances cytokine release in vivo","volume":"9","author":"Langenhorst","year":"2018","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B15","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.1601135","article-title":"Costimulation blockade in autoimmunity and transplantation: the CD28 pathway","volume":"197","author":"Adams","year":"2016","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/antib6040019","article-title":"Antagonist anti-CD28 therapeutics for the treatment of autoimmune disorders","volume":"6","author":"Vanhove","year":"2017","journal-title":"Antibodies (Basel)"},{"key":"2026081805465352900_vkag191-B17","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1600-6143.2012.04032.x","article-title":"CD28-specific immunomodulating antibodies: what can be learned from experimental models?","volume":"12","author":"Poirier","year":"2012","journal-title":"Am J Transplant"},{"key":"2026081805465352900_vkag191-B18","first-page":"111","article-title":"CD28 co-stimulation in T-cell homeostasis: a recent perspective","volume":"4","author":"Beyersdorf","year":"2015","journal-title":"Immunotargets Ther"},{"key":"2026081805465352900_vkag191-B19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri3192","article-title":"The storm has cleared: lessons from the CD28 superagonist TGN1412 trial","volume":"12","author":"Hunig","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026081805465352900_vkag191-B20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"2026081805465352900_vkag191-B21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1476-5381.2010.00922.x","article-title":"Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells","volume":"161","author":"Eastwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2026081805465352900_vkag191-B22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4049\/jimmunol.2100174","article-title":"Human-like response of pig T cells to superagonistic anti-CD28 monoclonal antibodies","volume":"207","author":"Uehlein","year":"2021","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B23","doi-asserted-by":"crossref","first-page":"e0149093","DOI":"10.1371\/journal.pone.0149093","article-title":"TGN1412 induces lymphopenia and human cytokine release in a humanized mouse model","volume":"11","author":"Weissmuller","year":"2016","journal-title":"PLoS One"},{"key":"2026081805465352900_vkag191-B24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2017.09.016","article-title":"Wild mouse gut microbiota promotes host fitness and improves disease resistance","volume":"171","author":"Rosshart","year":"2017","journal-title":"Cell"},{"key":"2026081805465352900_vkag191-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TXD.0000000000000516","article-title":"Anti-CD28 antibody-initiated cytokine storm in canines","volume":"1","author":"Rosinski","year":"2015","journal-title":"Transplant Direct"},{"key":"2026081805465352900_vkag191-B26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.immuni.2024.01.007","article-title":"Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases","volume":"57","author":"Lippert","year":"2024","journal-title":"Immunity"},{"key":"2026081805465352900_vkag191-B27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ni1170","article-title":"Crystal structure of a soluble CD28-Fab complex","volume":"6","author":"Evans","year":"2005","journal-title":"Nat Immunol"},{"key":"2026081805465352900_vkag191-B28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2017.00502","article-title":"ISA-2011B, a Phosphatidylinositol 4-phosphate 5-Kinase alpha inhibitor, impairs CD28-dependent costimulatory and pro-inflammatory signals in human T lymphocytes","volume":"8","author":"Kunkl","year":"2017","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.178.3.1363","article-title":"Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome","volume":"178","author":"Dennehy","year":"2007","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.161.4.1645","article-title":"A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement","volume":"161","author":"Siefken","year":"1998","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B31","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1073\/pnas.0308688101","article-title":"CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters","volume":"101","author":"Marinari","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081805465352900_vkag191-B32","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1182\/blood-2010-12-319780","article-title":"Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412","volume":"118","author":"Romer","year":"2011","journal-title":"Blood"},{"key":"2026081805465352900_vkag191-B33","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","article-title":"A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers","volume":"46","author":"Dietz","year":"2006","journal-title":"Transfusion"},{"key":"2026081805465352900_vkag191-B34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cancers13040785","article-title":"Cross-reactivity and functionality of approved human immune checkpoint blockers in dogs","volume":"13","author":"Pantelyushin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026081805465352900_vkag191-B35","author":"Beyersdorf","year":"2013"},{"key":"2026081805465352900_vkag191-B36","doi-asserted-by":"crossref","first-page":"iv91","DOI":"10.1136\/ard.2005.042564","article-title":"Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases","volume":"64","author":"Beyersdorf","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2026081805465352900_vkag191-B37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or Evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2026081805465352900_vkag191-B39","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.178.7.4222","article-title":"Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance","volume":"178","author":"Simson","year":"2007","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"2026081805465352900_vkag191-B41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ijc.32280","article-title":"Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration","volume":"145","author":"Schrama","year":"2019","journal-title":"Int J Cancer"},{"key":"2026081805465352900_vkag191-B42","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","article-title":"Phagocytosis: our current understanding of a universal biological process","volume":"11","author":"Uribe-Querol","year":"2020","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.LAB.0000098425.03006.42","article-title":"Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin","volume":"83","author":"Lugini","year":"2003","journal-title":"Lab Invest"},{"key":"2026081805465352900_vkag191-B44","doi-asserted-by":"crossref","first-page":"e2107663118","DOI":"10.1073\/pnas.2107663118","article-title":"d-Mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081805465352900_vkag191-B45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/imcb.12683","article-title":"Kevin Lafferty and the lymphocyte costimulator: theory and practice in Canberra","volume":"101","author":"Hodgkin","year":"2023","journal-title":"Immunol Cell Biol"},{"key":"2026081805465352900_vkag191-B46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/cimm.1996.1066","article-title":"CD28-mediated activation of resting human T cells without costimulation of the CD3\/TCR complex","volume":"176","author":"Siefken","year":"1997","journal-title":"Cell Immunol"},{"key":"2026081805465352900_vkag191-B47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"2026081805465352900_vkag191-B48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","article-title":"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma","volume":"89","author":"Boivin","year":"2009","journal-title":"Lab Invest"},{"key":"2026081805465352900_vkag191-B49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature22311","article-title":"Tumour ischaemia by interferon-gamma resembles physiological blood vessel regression","volume":"545","author":"Kammertoens","year":"2017","journal-title":"Nature"},{"key":"2026081805465352900_vkag191-B50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/membranes10120406","article-title":"Lysosomal exocytosis: the extracellular role of an intracellular organelle","volume":"10","author":"Tancini","year":"2020","journal-title":"Membranes (Basel)"},{"key":"2026081805465352900_vkag191-B51","doi-asserted-by":"crossref","first-page":"e954893","DOI":"10.4161\/21624011.2014.954893","article-title":"A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines","volume":"3","author":"Boegel","year":"2014","journal-title":"Oncoimmunology"},{"key":"2026081805465352900_vkag191-B52","doi-asserted-by":"crossref","first-page":"13789","DOI":"10.1073\/pnas.212456599","article-title":"Natural killer cells attack tumor cells expressing high levels of Sialyl Lewis x oligosaccharides","volume":"99","author":"Ohyama","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081805465352900_vkag191-B53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01540972","article-title":"Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation","volume":"16","author":"Jewett","year":"1996","journal-title":"J Clin Immunol"},{"key":"2026081805465352900_vkag191-B54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1600-065X.2003.00044.x","article-title":"Granzyme B: a natural born killer","volume":"193","author":"Lord","year":"2003","journal-title":"Immunol Rev"},{"key":"2026081805465352900_vkag191-B55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2026081805465352900_vkag191-B56","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.4049\/jimmunol.144.10.4068","article-title":"Rejection of mouse sarcoma cells after transfection of MHC class II genes","volume":"144","author":"Ostrand-Rosenberg","year":"1990","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"2026081805465352900_vkag191-B58","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"Perez-Diez","year":"2007","journal-title":"Blood"},{"key":"2026081805465352900_vkag191-B59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J Exp Med"},{"key":"2026081805465352900_vkag191-B60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"2026081805465352900_vkag191-B61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"2026081805465352900_vkag191-B62","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"2026081805465352900_vkag191-B63","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J Immunol"},{"key":"2026081805465352900_vkag191-B64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/cimm.1993.1100","article-title":"The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells","volume":"148","author":"Lauritzsen","year":"1993","journal-title":"Cell Immunol"},{"key":"2026081805465352900_vkag191-B65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"2026081805465352900_vkag191-B66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)80218-6","article-title":"CD4+ T cell\u2014mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells","volume":"12","author":"Qin","year":"2000","journal-title":"Immunity"},{"key":"2026081805465352900_vkag191-B67","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00262-019-02369-x","article-title":"CTLA-4 antibody ipilimumab negatively affects CD4(+) T-cell responses in vitro","volume":"68","author":"Rosskopf","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2026081805465352900_vkag191-B68","first-page":"174","article-title":"How do CD4(+) T cells detect and eliminate tumor cells that either lack or express MHC Class II","volume":"5","author":"Haabeth","year":"2014","journal-title":"Molecules? Front Immunol"},{"key":"2026081805465352900_vkag191-B69","first-page":"41","article-title":"Cell isolation and expansion using Dynabeads","volume":"106","author":"Neurauter","year":"2007","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"2026081805465352900_vkag191-B70","doi-asserted-by":"crossref","first-page":"5474602","DOI":"10.1155\/2016\/5474602","article-title":"CAR T cell therapy: a game changer in cancer treatment","volume":"2016","author":"Almasbak","year":"2016","journal-title":"J Immunol Res"},{"key":"2026081805465352900_vkag191-B71","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fimmu.2017.01642","article-title":"Scrambled eggs: apoptotic cell clearance by non-professional phagocytes in the drosophila ovary","volume":"8","author":"Serizier","year":"2017","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41577-023-00921-6","article-title":"Cell death by phagocytosis","volume":"24","author":"Brown","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026081805465352900_vkag191-B73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026081805465352900_vkag191-B74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-based drug delivery in Cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front Mol Biosci"},{"key":"2026081805465352900_vkag191-B75","doi-asserted-by":"crossref","first-page":"603039","DOI":"10.3389\/fimmu.2020.603039","article-title":"Nanoparticle-induced complement activation: implications for Cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front Immunol"},{"key":"2026081805465352900_vkag191-B76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jfb8020012","article-title":"Endovascular embolization by transcatheter delivery of particles: past, present, and future","volume":"8","author":"Sheth","year":"2017","journal-title":"J Funct Biomater"},{"key":"2026081805465352900_vkag191-B77","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1158\/0008-5472.CAN-09-0400","article-title":"In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer","volume":"69","author":"Ugel","year":"2009","journal-title":"Cancer Res"},{"key":"2026081805465352900_vkag191-B78","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am J Pathol"},{"key":"2026081805465352900_vkag191-B79","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41467-018-03385-8","article-title":"A non-conserved amino acid variant regulates differential signalling between human and mouse CD28","volume":"9","author":"Porciello","year":"2018","journal-title":"Nat Commun"},{"key":"2026081805465352900_vkag191-B80","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.2023023381","article-title":"CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy","volume":"143","author":"Sam","year":"2024","journal-title":"Blood"},{"key":"2026081805465352900_vkag191-B81","doi-asserted-by":"crossref","first-page":"789069","DOI":"10.1155\/2014\/789069","article-title":"The \u201cTrojan Horse\u201d approach to tumor immunotherapy: targeting the tumor microenvironment","volume":"2014","author":"Nelson","year":"2014","journal-title":"J Immunol Res"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/8\/vkag191\/70678047\/vkag191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/8\/vkag191\/70678047\/vkag191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:47:06Z","timestamp":1787046426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkag191\/8763155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkag191","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"vkag191"}}